These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3160356)

  • 1. Nitrendipine and atenolol: comparison and combination in the treatment of arterial hypertension.
    de Divitiis O; Petitto M; Di Somma S; Galderisi M; Villari B; Santomauro M; Fazio S
    Arzneimittelforschung; 1985; 35(4):727-9. PubMed ID: 3160356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nifedipine and atenolol singly and combined for treatment of essential hypertension: comparative multicentre study in general practice in the United Kingdom. Nifedipine-Atenolol Study Review Committee.
    Nifedipine-Atenolol Study Review Committee
    Br Med J (Clin Res Ed); 1988 Feb; 296(6620):468-72. PubMed ID: 2894883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension.
    Schoenberger JA; Glasser SP; Ram CV; McMahon SG; Vanov SK; Leibowitz DA
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1105-8. PubMed ID: 6085376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muzolimine and nitrendipine in the treatment of arterial hypertension.
    de Divitiis O; Di Somma S; Petitto M; Galderisi M; Iacono C; Fazio S
    Z Kardiol; 1985; 74 Suppl 2():60-5. PubMed ID: 3159163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris].
    Verdecchia P
    Minerva Cardioangiol; 1993 Sep; 41(9):349-63. PubMed ID: 7903118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effectiveness of BAY e 5009-nitrendipine in the treatment of mild and moderate arterial hypertension.
    Esper RJ; Esper RC; Baglivo HP; Castro JM; Rohwedder RW; Menna J
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1096-9. PubMed ID: 6085374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crossover comparison of nitrendipine with propranolol in patients with essential hypertension.
    Fritschka E; Distler A; Gotzen R; Thiede HM; Philipp T
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1100-4. PubMed ID: 6085375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Felodipine in arterial hypertension. Double-blind comparison with atenolol].
    Andrejak M; Witchitz S; Morand P; Lesbre JP; Raveau-Landon C
    Therapie; 1989; 44(3):167-70. PubMed ID: 2675377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of once-daily nifedipine coat-core in combination with atenolol in hypertensive patients. Adalat CC Cooperative Study Group.
    Mac Carthy EP; Pettis PP; Gibson L; Schwartz L; Feig PU
    Clin Ther; 1993; 15(6):976-87. PubMed ID: 8111817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term hypotensive treatment with nitrendipine in mild to moderate essential hypertension: preliminary results of a placebo-controlled study versus atenolol.
    Palombo C; Marabotti C; Genovesi-Ebert A; Giuliano G; Giaconi S; Fommei E; Mezzasalma L; Ghione S
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S90-5. PubMed ID: 2455153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
    Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
    Colnago R; Meregalli M; Turri D; Nazzari M; Fiorella G; Guffanti EE; Mazzola C
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative antihypertensive action of 20 mg delayed-action nifedipine with either 25 or 50 mg atenolol. A study on the treatment of patients with mild to moderately severe arterial hypertension].
    Kraft K; Schiessl S; Vetter H
    Praxis (Bern 1994); 1996 Sep; 85(36):1081-6. PubMed ID: 8927880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative trial of nifedipine retard and atenolol in the treatment of elderly patients with mild to moderate hypertension.
    Clamp M; Holmes B; Wilcox R
    J Hum Hypertens; 1990 Oct; 4(5):557-63. PubMed ID: 2283646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with long-term nitrendipine treatment in essential hypertension.
    Tourkantonis A; Lasaridis A; Settas L
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1090-5. PubMed ID: 6085373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of nitrendipine in patients with severe hypertension: a multiclinic study.
    Jain AK; McMahon FG; Ryan JR; Maronde R; Vlachakis N; Mroczek W
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1053-9. PubMed ID: 6085366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of nisoldipine and atenolol in the treatment of essential hypertension.
    Takahashi H; Fukuyama M; Yoneda S; Okabayashi H; Yoshimura M
    Arzneimittelforschung; 1989 Mar; 39(3):379-82. PubMed ID: 2667523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril compared to atenolol in mild to moderate hypertension in a randomized double-blind controlled trial.
    Havinga TK; ten Berge BS; May JF; Schuurman FH; van der Veur E; Wesseling H
    Neth J Med; 1991 Feb; 38(1-2):13-7. PubMed ID: 2030804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.